At the time of writing, Lilly(Eli) & Co [LLY] stock is trading at $782.12, up 3.77%. An important factor to consider is whether the stock is rising or falling in short-term value. The LLY shares have gain 1.63% over the last week, with a monthly amount glided 21.14%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 20, February 2024, Lilly to Participate in Cowen’s 44th Annual Health Care Conference. In a post published today on Yahoo Finance, Eli Lilly and Company (NYSE: LLY) will participate in Cowen’s 44th Annual Health Care Conference on March 6, 2024. Anat Ashkenazi, executive vice president and chief financial officer, will take part in a fireside chat at 9:10 a.m., Eastern time.
From an analyst’s perspective:
Lilly(Eli) & Co [NYSE: LLY] stock has seen the most recent analyst activity on February 21, 2024, when DZ Bank downgraded its rating to a Hold but kept the price target unchanged to $820 for it. Previously, Morgan Stanley reaffirmed its Overweight rating on February 16, 2024, and elevated its price target to $950. On December 21, 2023, downgrade downgraded it’s rating to Outperform and revised its price target to $610 on the stock. Deutsche Bank started tracking the stock assigning a Hold rating and suggested a price target of $535 on November 09, 2023. Jefferies upgraded its rating to Buy for this stock on August 09, 2023, and upped its price target to $615. In a note dated July 26, 2023, Citigroup reiterated an Buy rating on this stock and boosted its target price from $360 to $525.
For the past year, the stock price of Lilly(Eli) & Co fluctuated between $309.20 and $794.47. Currently, Wall Street analysts expect the stock to reach $421.78 within the next 12 months. Lilly(Eli) & Co [NYSE: LLY] shares were valued at $782.12 at the most recent close of the market. An investor can expect a potential drop of -46.07% based on the average LLY price forecast.
Analyzing the LLY fundamentals
According to Lilly(Eli) & Co [NYSE:LLY], the company’s sales were 34.12B for trailing twelve months, which represents an 28.10% jump. Gross Profit Margin for this corporation currently stands at 0.8% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.19%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.47 and Total Capital is 0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.34.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 769.47 points at the first support level, and at 756.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 789.42, and for the 2nd resistance point, it is at 796.73.
Lilly(Eli) & Co [LLY] reported earnings per share of $2.49 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $2.22/share, meaning a difference of $0.27 and a surprise factor of 12.20%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.1 per share as compared to estimates of -$0.13 per share, a difference of $0.23 representing a surprise of 176.90%.
Ratios To Look Out For
It is important to note that Lilly(Eli) & Co [NYSE:LLY] has a current ratio of 0.94. On the other hand, the Quick Ratio is 0.73, and the Cash Ratio is 0.1. Considering the valuation of this stock, the price to sales ratio is 21.78, the price to book ratio is 68.93 and price to earnings (TTM) ratio is 137.58.
Transactions by insiders
Recent insider trading involved LILLY ENDOWMENT INC, 10% Owner, that happened on Feb 16 when 0.17 million shares were sold. 10% Owner, LILLY ENDOWMENT INC completed a deal on Feb 15 to sell 50316.0 shares. Meanwhile, 10% Owner LILLY ENDOWMENT INC sold 0.21 million shares on Feb 09.
